CBOE vs SGMO · P/E 24, rev $2.72B vs rev $57.8M
Cboe Global Markets Inc (CBOE) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported CBOE revenue for 2026-06-30 was $2.72B. Net income was $738.8M. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the CBOE and SGMO stock pages for the full models.
Not investment advice.